NexGel, Inc. (NXGL) - Q3 2025 10-Q Summary
Business Context and Reporting Period
This summary covers NexGel, Inc.'s Form 10-Q for the quarterly period ended September 30, 2025. NexGel manufactures high water content hydrogels for wound care, medical diagnostics, and cosmetics. The company operates through two primary segments: the NexGel segment (contract manufacturing, branded consumer products like MedaGel, Kenkoderm, and Silly George) and the CGN segment (a 50% joint venture for converting and packaging). The company is classified as a non-accelerated filer, smaller reporting company, and emerging growth company.
Key Financial Metrics
| Metric | Q3 2025 (3 Months) | Q3 2024 (3 Months) | YTD 2025 (9 Months) | YTD 2024 (9 Months) |
|---|---|---|---|---|
| Revenue | $2,934,000 | $2,940,000 | $8,625,000 | $5,647,000 |
| Gross Profit | $1,243,000 | $1,155,000 | $3,690,000 | $1,674,000 |
| Gross Margin | 42.4% | 39.2% | 42.8% | 29.6% |
| Net Loss (Attributable to NexGel) | $(653,000) | $(693,000) | $(2,030,000) | $(2,431,000) |
| Net Loss Per Share (Basic/Diluted) | $(0.08) | $(0.11) | $(0.26) | $(0.39) |
| Cash & Equivalents | $938,000 (as of Sept 30, 2025) | |||
| Restricted Cash | $920,000 (as of Sept 30, 2025) | |||
| Total Debt (Notes Payable) | $614,000 (Total principal) | |||
| Working Capital | $2,294,000 (as of Sept 30, 2025) |
Material Changes vs. Prior Period
- Revenue Growth: Year-to-date revenue increased 52.7% to $8.6 million, driven primarily by the full-year impact of the Silly George acquisition (beauty products) and growth in branded consumer products. Q3 revenue remained flat compared to the prior year quarter.
- Margin Expansion: Gross margin improved significantly to 42.8% YTD from 29.6% in the prior year, attributed to decreased depreciation and amortization expenses and higher-margin consumer product sales.
- Operating Expenses: Selling, General, and Administrative (SG&A) expenses increased 35.1% YTD to $5.8 million. This was driven by higher compensation, share-based compensation (up 96.7%), and increased marketing/Amazon fees to support brand growth.
- Loss Reduction: Net loss attributable to stockholders decreased to $2.0 million YTD from $2.4 million in the prior year, despite higher operating expenses, due to revenue growth and non-operating income (changes in fair value of warrant liability).
Guidance, Outlook, Risks, and Contingencies
- Going Concern: Management has raised substantial doubt about the company's ability to continue as a going concern. The company incurred a net loss of $2.0 million YTD and used $1.6 million in operating cash. While working capital is positive ($2.3 million), future capital raises (debt or equity) may be necessary.
- Capital Raises: In August 2025, the company completed an equity offering raising approximately $950,000. Additionally, a $1.0 million non-dilutive advance was received from partner STADA Arzneimittel AG for product launches; $920,000 of this is currently held as restricted cash.
- Legal Proceedings: NexGel filed a declaratory judgment lawsuit against Kiss Nail Products, Inc. regarding a patent dispute over Silly George eyelash products. NexGel believes the patent is invalid, but an adverse ruling could result in product removal from Amazon, causing material harm.
- Internal Controls: The company disclosed that its disclosure controls and procedures were not effective as of September 30, 2025, due to material weaknesses including lack of segregation of duties and improper fair value adjustments.
- Outlook: Management plans to expand into adjacent industries (cosmetics, athletic products) and proprietary medical devices. No specific financial guidance was provided.
Investor Verification Checklist
- Liquidity Runway: Verify the burn rate against the $938k unrestricted cash balance to assess the timeline for potential dilution or debt financing.
- Restricted Cash Usage: Confirm the terms of the $920k STADA advance and the specific milestones required to unlock these funds for general operations.
- Legal Risk Exposure: Monitor the status of the patent litigation with Kiss Nail Products, as a loss could materially impact the Silly George revenue stream.
- Internal Control Remediation: Review future filings for progress on remediating the material weaknesses in financial reporting controls.
- Customer Concentration: Note that while no single customer exceeded 10% of revenue YTD 2025, one customer held 50% of accounts receivable, indicating concentration risk.